Stock LENZ LENZ THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart LENZ Therapeutics, Inc.

Equities

LENZ

US52635N1037

Real-time Estimate Cboe BZX
Other stock markets
 03:02:25 2024-05-23 pm EDT 		5-day change 1st Jan Change
15.43 USD -16.19% Intraday chart for LENZ Therapeutics, Inc. -6.02% 0.00%
Apr. 15 Leerink Partners Starts LENZ Therapeutics With Outperform Rating, $32 Price Target MT
Apr. 15 William Blair Starts LENZ Therapeutics With Outperform Rating MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
LENZ THERAPEUTICS, INC. Stock LENZ Therapeutics, Inc.
 470M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 115B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 24.69B -
ARGENX SE Stock argenx SE
 21.97B -
GENMAB A/S Stock Genmab A/S
 19.27B
  1. Stock Market
  2. Equities
  3. LENZ Stock
  4. Charts LENZ Therapeutics, Inc.
  5. Sector Chart